The country's medical regulator has approved a cocktail of monoclonal antibodies for restricted emergency use to treat mild to moderate COVID-19 patients. This therapy was spoken about last year when it was used to treat former US President Donald Trump. So will monoclonal antibody therapy be a gamechanger as many have predicted?
